KRAS and neoplasm: For example, the C2 and C3 clusters exhibited obviously metabolic re-program characteristics, while C1 and C4 demonstrated a strong immune stress response of immune cells no matter which tissue they were derived from in tumor patients, and cluster C1 indicated that the expression of immune checkpoint inhibitors may be associated with the KRAS pathway.